Par installs Pera as commercial head

Share this article:

Par Pharmaceuticals named Antonio Pera as chief commercial officer. Pera previously worked as SVP, commercial operations, JHP Pharmaceuticals, which was acquired by Par at the end of January. In his new role, Pera will manage the organization's relationships with major trade partners.

Pera also worked at AmeriSourceBergen as SVP, supply chain management.

"He has a demonstrated expertise in the marketing, sales and distribution of generic drugs," stated Paul Campanelli, CEO of Par, adding, “We look forward to the leadership Tony will provide our commercial organization and the many contributions he will make to our company."

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.